Jaume Capdevila

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Alice Dewdney, David Cunningham, Josep Tabernero et al. · Journal of Clinical Oncology · 2012 · 390 citations · Full text

Medicine, Oncology, Surgery +17

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

Maxime J.M. van der Valk, Corrie A.M. Marijnen, Boudewijn van Etten et al. · Radiotherapy and Oncology · 2020 · 214 citations · Full text

Medicine, Oncology, Surgery +16

Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer

Garazi Serna, Fiorella Ruíz‐Pace, Jorge Hernando et al. · Annals of Oncology · 2020 · 150 citations · Full text

Medicine, Microbiology, Oncology +17

Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients

Esther Roé, Maria Pilar García Muret, Eugenio Marcuello et al. · Journal of the American Academy of Dermatology · 2006 · 145 citations

Pharmacy, Oncology, Pharmacotherapy +15